Related topics

BioScrip: 2Q Earnings Snapshot

August 7, 2018

DENVER (AP) _ BioScrip Inc. (BIOS) on Tuesday reported a loss of $15.1 million in its second quarter.

On a per-share basis, the Denver-based company said it had a loss of 14 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.

The infusion and home care services company posted revenue of $175.8 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected $169 million.

BioScrip expects a full-year loss of 40 cents to 34 cents per share.

The company’s shares closed at $2.75. A year ago, they were trading at $2.66.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIOS at https://www.zacks.com/ap/BIOS

Update hourly